Bruce J. Averbook

1.0k total citations
20 papers, 603 citations indexed

About

Bruce J. Averbook is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, Bruce J. Averbook has authored 20 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 11 papers in Immunology and 3 papers in Surgery. Recurrent topics in Bruce J. Averbook's work include CAR-T cell therapy research (9 papers), Immunotherapy and Immune Responses (9 papers) and Cutaneous Melanoma Detection and Management (7 papers). Bruce J. Averbook is often cited by papers focused on CAR-T cell therapy research (9 papers), Immunotherapy and Immune Responses (9 papers) and Cutaneous Melanoma Detection and Management (7 papers). Bruce J. Averbook collaborates with scholars based in United States, India and Israel. Bruce J. Averbook's co-authors include Edward G. Mansour, Steven A. Rosenberg, Robert S. Papay, James J. Mulé, James C. Yang, Thomas J. Schall, Jeffrey S. Weber, Mary Custer, David V. Goeddel and Jørgen Kjaergäard and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Surgery.

In The Last Decade

Bruce J. Averbook

20 papers receiving 589 citations

Peers

Countries citing papers authored by Bruce J. Averbook

Since Specialization

Citations

This map shows the geographic impact of Bruce J. Averbook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce J. Averbook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce J. Averbook more than expected).

Fields of papers citing papers by Bruce J. Averbook

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce J. Averbook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce J. Averbook. The network helps show where Bruce J. Averbook may publish in the future.

Co-authorship network of co-authors of Bruce J. Averbook

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce J. Averbook. A scholar is included among the top collaborators of Bruce J. Averbook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce J. Averbook. Bruce J. Averbook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Staging breast cancer by sentinel lymph node biopsy: Do patients with a single negative sentinel node (N=1) experience worse outcomes than those with multiple negative sentinel nodes (N>1)? 2018 ·Surgical Oncology ·(unknown), Bruce J. Averbook, Natalie E. Joseph, Susan Sharpe, Benjamin Li	1
2	Safety and Feasibility of Minimally Invasive Inguinal Lymph Node Dissection in Patients With Melanoma (SAFE-MILND) 2016 ·Annals of Surgery ·James W. Jakub, Alicia M. Terando, Amod A. Sarnaik, Charlotte E. Ariyan, Mark B. Faries, Sabino Zani, Heather B. Neuman, Nabil Wasif, Jeffrey M. Farma, Bruce J. Averbook, Karl Y. Bilimoria, Travis E. Grotz, Jacob B. Allred, Vera J. Suman, Mary Sue Brady, Douglas S. Tyler, Jeffrey D. Wayne, Heidi D Nelson	27
3	Laparoscopic skill assessment of practicing surgeons prior to enrollment in a surgical trial of a new laparoscopic procedure 2016 ·Surgical Endoscopy ·Benjamin Zendejas, James W. Jakub, Alicia M. Terando, Amod A. Sarnaik, Charlotte E. Ariyan, Mark B. Faries, Sabino Zani, Heather B. Neuman, Nabil Wasif, Jeffrey M. Farma, Bruce J. Averbook, Karl Y. Bilimoria, Douglas S. Tyler, Mary Sue Brady, David R. Farley	15
4	Training High-Volume Melanoma Surgeons to Perform a Novel Minimally Invasive Inguinal Lymphadenectomy: Report of a Prospective Multi-Institutional Trial 2015 ·Journal of the American College of Surgeons ·James W. Jakub, Alicia M. Terando, Amod A. Sarnaik, Charlotte E. Ariyan, Mark B. Faries, Sabino Zani, Heather B. Neuman, Nabil Wasif, Jeffrey M. Farma, Bruce J. Averbook, Karl Y. Bilimoria, Jacob B. Allred, Vera J. Suman, Travis E. Grotz, Benjamin Zendejas, Jeffrey D. Wayne, Douglas S. Tyler	13
5	Pediatric melanoma: Analysis of an international registry 2013 ·Cancer ·Bruce J. Averbook, Sandra J. Lee, Keith A. Delman, Kenneth W. Gow, Jonathan S. Zager, Vernon K. Sondak, Jane L. Messina, Michael S. Sabel, Mark R. Pittelkow, (unknown), Svetomir N. Markovic, Susan M. Swetter, Sancy A. Leachman, Alessandro Testori, Clara Curiel‐Lewandrowski, Ronald S. Go, D.M. Jukic, John M. Kirkwood	53
6	Combined Analysis of Phase III Trials Evaluating [99mTc]Tilmanocept and Vital Blue Dye for Identification of Sentinel Lymph Nodes in Clinically Node-Negative Cutaneous Melanoma 2012 ·Annals of Surgical Oncology ·Vernon K. Sondak, Dennis W. King, Jonathan S. Zager, Schlomo Schneebaum, Julian Kim, Stanley P. L. Leong, Mark B. Faries, Bruce J. Averbook, Steve R. Martinez, Christopher A. Puleo, Jane L. Messina, Lori Christman, Anne M. Wallace	106
7	A phase II trial of dasatinib in patients with unresectable locally advanced or stage IV mucosal, acral, and solar melanomas: An Eastern Cooperative Oncology Group study (E2607). 2012 ·Journal of Clinical Oncology ·Kevin Kalinsky, Sandra J. Lee, Donald P. Lawrence, A. John Iafrate, Darrell R. Borger, Bruce J. Averbook, Ahmad A. Tarhini, John M. Kirkwood	7
8	Melanoma in Pediatric, Adolescent, and Young Adult Patients 2009 ·Seminars in Oncology ·John M. Kirkwood, D.M. Jukic, Bruce J. Averbook, Leonard S. Sender	21
9	First analysis of an international pediatric melanoma and atypical melanocytic neoplasm database 2009 ·Journal of Clinical Oncology ·Bruce J. Averbook, D.M. Jukic, Jia‐Sheng Rao, A. Panneerselvam, Keith A. Delman, Jonathan S. Zager, Michael S. Sabel, Mark R. Pittelkow, Susan M. Swetter, John M. Kirkwood	1
10	A long-term analysis of 1018 patients with melanoma by classic Cox regression and tree-structured survival analysis at a major referral center: Implications on the future of cancer staging 2002 ·Surgery ·Bruce J. Averbook, Pingfu Fu, J. Sunil Rao, Edward G. Mansour	34
11	Immunogenicity and Therapeutic Efficacy of Dendritic–Tumor Hybrid Cells Generated by Electrofusion 2002 ·Clinical Immunology ·Takashi Hayashi, Hiroshi Tanaka, Junta Tanaka, Rongfu Wang, Bruce J. Averbook, Peter A. Cohen, Suyu Shu	69
12	Antitumor Effects of Flt3 Ligand in Transplanted Murine Tumor Models 2002 ·Journal of Immunotherapy ·Bruce J. Averbook, JoAnn C. L. Schuh, Robert S. Papay, Charles R. Maliszewski	14
13	Divergent effects of 4-1BB antibodies on antitumor immunity and on tumor-reactive T-cell generation. 2001 ·PubMed ·Julian A. Kim, Bruce J. Averbook, Karen Chambers, (unknown), Jørgen Kjaergäard, Robert S. Papay, (unknown)	74
14	Coinfusion of Irradiated Splenocytes with Low Titer Tumor-Infiltrating Lymphocytes Augments Antitumor Efficacy in Adoptive Immunotherapy 1999 ·Journal of Immunotherapy ·Bruce J. Averbook, Ronald P. Cleveland, Chad Viscusi, Robert S. Papay	2
15	A long-term analysis of 620 patients with malignant melanoma at a major referral center 1998 ·Surgery ·Bruce J. Averbook, Leo Russo, Edward G. Mansour	24
16	RANTES Secretion by Gene-Modified Tumor Cells Results in Loss of Tumorigenicity In Vivo: Role of Immune Cell Subpopulations 1996 ·Human Gene Therapy ·James J. Mulé, Mary Custer, Bruce J. Averbook, James C. Yang, Jeffrey S. Weber, David V. Goeddel, Steven A. Rosenberg, Thomas J. Schall	115
17	A tumor-elaborated supernatant factor chemotactic for IL-2 expanded tumor infiltrating T-lymphocytes. 1993 ·PubMed ·Bruce J. Averbook, (unknown), Donna Perry-Lalley, Steven A. Rosenberg, James Chih‐Hsin Yang	6
18	Human alpha lymphotoxin (LT): studies examining the mechanism(s) of LT-induced inflammation and tumor destruction in vivo. 1987 ·PubMed ·Edward W. B. Jeffes, Bruce J. Averbook, Thomas R. Ulich, Gale A. Granger	1
19	Purified native and recombinant human alpha lymphotoxin [tumor necrosis factor (TNF)-beta] induces inflammatory reactions in normal skin 1987 ·Journal of Clinical Immunology ·Bruce J. Averbook, Robert S. Yamamoto, Thomas R. Ulich, Edward W. B. Jeffes, (unknown), Gale A. Granger	11
20	Electrophysiologic changes associated with chronic administration of organophosphates 1983 ·Archives of Toxicology ·Bruce J. Averbook, Rebecca Anderson	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact